Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
The groundbreaking work of modern genetics that culminated in the Human Genome Project has blazed new pathways in both science and law. As the assertion of property rights generally, and patents in particular, has become increasingly common surrounding the new products and processes of modern biotechnology, the transactions that must occur for downstream research and development to occur have shifted in important ways, in both academic and business settings. Perspectives on Properties of the Human Genome Project addresses the problems raised in this complex area under different regimes of laws and norms to offer hope and help as we wrestle to ensure optimal use of such essential innovations. This unique collection of authors, views, and topics is essential reading for academics, policy-makers, and practitioners in medicine, biology, sociology, management, ethics, law, and economics, and anyone else interested in gaining perspective on the broad interface between biotechnology and property.
- Represents diverse views interwoven into a coherent dialogue
- Includes contributions from the leading thinkers in the field
- Explores the legal ramifications, in terms of property rights and patents, of the scientific developments arising from the work on the Human Genome Project
Academics in biology, ethics, and sociology, as well as biotechnology and pharmaceutical companies.
- No. of pages:
- © Academic Press 2003
- 17th December 2003
- Academic Press
- Hardcover ISBN:
- eBook ISBN:
"This is a gem of a book... [by] a veritable ‘who’s who’ of important contributors to this field…. An interested reader could not ask for a better overview and compendium of serious, thoughtful analysis of this important topic." –Professor Robert P. Merges, University of California at Berkeley School of Law
"Kieff’s timely and masterful book establishes a modern truth: to translate a scientific discovery into tangible patient benefits requires an intellectual property lawyer. [It] should be read not only by legal scholars but also scientists and the general public." –Dr. Mark Siegler, University of Chicago Pritzker School of Medicine